Ha kapcsolatba szeretne lépni a Tudóstér adminisztrátoraival, kérjük töltse ki az alábbi űrlapot, vagy küldjön e-mailt a publikacioklib.unideb.hu címre.
Bejelentkezés
A Tudóstér funkcióinak nagy része bejelentkezés nélkül is elérhető. Bejelentkezésre az alábbi műveletekhez van szükség:
Lengyel, M.,
Molnár, Á.,
Nagy, T.,
Jdeed, S.,
Garai, I.,
Horváth, Z.,
Uray, I. P.:
Zymogen granule protein 16B (ZG16B) is a druggable epigenetic target to modulate the mammary extracellular matrix.
Cancer Sci. 116 (1), 81-94, 2025.
Jambrovics, K.,
Póliska, S.,
Scholtz, B.,
Uray, I. P.,
Balajthy, Z.:
ATO Increases ROS Production and Apoptosis of Cells by Enhancing Calpain-Mediated Degradation of the Cancer Survival Protein TG2.
Int. J. Mol. Sci. 24 (13), 1-11, (cikkazonosító: 10938), 2023.
Jdeed, S.,
Lengyel, M.,
Uray, I. P.:
Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal Breast Cells through TGF-[béta] Signaling.
Cells. 11 (17), 1-15, (cikkazonosító: 2633), 2022.
Jambrovics, K.,
Uray, I. P.,
Keillor, J. W.,
Fésüs, L.,
Balajthy, Z.:
Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2.
Cancers (Basel). 12 (3), 648-, 2020.
Kocsis, J.,
Szekanecz, É.,
Bassam, A.,
Uhlyarik, A.,
Pápai, Z.,
Rubovszky, G.,
Mezősi, E.,
Rucz, K.,
Garai, I.,
Nagy, E. V.,
Uray, I. P.,
Horváth, Z.:
First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: efficacy and Safety Analysis.
Exp. Clin. Endocrinol. Diabetes. 127 (4), 240-246, 2019.
Jambrovics, K.,
Uray, I. P.,
Keresztessy, Z.,
Keillor, J. W.,
Fésüs, L.,
Balajthy, Z.:
Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-kB activation.
Haematol-Hematol. J. 104 (3), 505-515, 2019.
Chowdhury, P.,
Powell, R. T.,
Stephan, C.,
Uray, I. P.,
Talley, T.,
Karki, M.,
Tripathi, D. N.,
Park, Y. S.,
Mancini, M. A.,
Davies, P. J. A.,
Dere, R.:
Bexarotene: a Novel Modulator of AURKA and the Primary Cilium in VHL-deficient Cells.
J. Cell Sci. 131, 1-12, 2018.
Shepherd, J. H.,
Uray, I. P.,
Mazumdar, A.,
Tsimelzon, A.,
Savage, M.,
Hilsenbeck, S. G.,
Brown, P. H.:
The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
Oncotarget. 7 (11), 1-16, 2016.
Uray, I. P.,
Rodenberg, J. M.,
Zhang, Y.,
Hill, J. L.,
Brown, P. H.:
Abstract 2804: The thiazolidinedione pioglitazone enhances the cancer preventive activity of the rexinoid LG100268 in Her2/neu induced breast cancer.
Cancer Res. 75 (15), 2804, 2015.
Shen, J.,
Peng, Y.,
Wei, L.,
Zhang, W.,
Yang, L.,
Lan, L.,
Kapoor, P.,
Ju, Z.,
Mo, Q.,
Shih, I. M.,
Uray, I. P.,
Wu, X.,
Brown, P. H.,
Shen, X.,
Mills, G. B.,
Peng, G.:
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
Cancer Discov. 5 (7), 752-767, 2015.
Batra, N.,
Speers, C.,
Uray, I. P.,
Mazumdar, A.,
Tsimelzon, A.,
Hilsenbeck, S. G.,
Mills, G. B.,
Brown, P. H.:
Abstract 3299: Maternal embryonic leucine zipper kinase is critical for the growth and migration of triple negative breast cancer cells.
Cancer Res. 74 (19), 3299-3299, 2014.
Xiong, A.,
Chen, H.,
Yang, Z.,
Cai, G.,
Wang, L.,
Ding, C.,
Xu, G. G.,
Wild, C.,
Ye, N.,
Uray, I. P.,
Zhou, J.,
Shen, Q.:
Abstract 3805: Anticancer agent HJC0416 inhibits the growth of breast cancer xenografts via downregulating STAT3 signaling.
Cancer Res. 74 (19), 3805-3805, 2014.
Hartman, Z. C.,
Tsimelzon, A.,
Uray, I. P.,
Hill, J. L.,
Zhang, Y.,
Mazumdar, A.,
Hilsenbeck, S. G.,
Chang, J.,
Mills, G. B.,
Brown, P. H.:
Abstract 4862: Autocrine secreted IL-6 and IL-8 play critical and non-redundant roles in basal-like breast cancer cell transformation and growth in vitro and in vivo.
Cancer Res. 72 (8), 4862-4862, 2012.
Wang, C.,
Uray, I. P.,
Mazumdar, A.,
Mayer, J. A.,
Brown, P. H.:
SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
Breast Cancer Res. Treat. 134 (1), 101-115, 2012.
Uray, I. P.,
Rodenberg, J. M.,
Bissonnette, R. P.,
Brown, P. H.,
Mancini, M. A.:
Cancer-Preventive Rexinoid Modulates Neutral Lipid Contents of Mammary Epithelial Cells through a Peroxisome Proliferator-Activated Receptor [gamma]-Dependent Mechanism.
Molecular Pharmacology. 81 (2), 228-238, 2011.
Uray, I. P.,
Brown, P. H.:
Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
Recent Results Cancer Res. 188, 147-162, 2011.
